Skip to main content
Watch Insiders
PTCT filings

Corporate insider profile

Mark Elliott Boulding Filing Activity

Latest reported as EXEC. VP AND CLO of PTC THERAPEUTICS, INC. (PTCT).

Purchase filings
0
Reported companies
1
Net open-market value
-$1,941,640.92
Latest transaction
Aug 17, 2026

Affiliated corporations

Reported company relationships

PTCTLatest reported

PTC THERAPEUTICS, INC.

EXEC. VP AND CLO

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 17, 2026PTC THERAPEUTICS, INC. (PTCT)EXEC. VP AND CLOSale2,813$72.57$204,127
Jul 6, 2026PTC THERAPEUTICS, INC. (PTCT)EXEC. VP AND CLOSale5,079$85.08$432,118
Jun 17, 2026PTC THERAPEUTICS, INC. (PTCT)EXEC. VP AND CLOSale10,462$78.65$822,868
🔒 Unlock Real-Time Alerts and 2 More High-Conviction Rows — Subscribe to Watch Insiders Premium